08/11/2025
7:01 AM | Karyopharm Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/11/2025
6:31 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2025
6:34 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2025
3:56 PM | Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2025
4:18 PM | Abate Kristin (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
8:34 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Karyopharm Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/11/2025
6:28 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2025
3:28 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2025
3:12 PM | Karyopharm Therapeutics (Issuer)
Oliger Christy J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
3:13 PM | Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
3:15 PM | Karyopharm Therapeutics (Issuer)
Su Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for KPTI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Karyopharm Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/24/2025
3:40 PM | Karyopharm Therapeutics (Issuer)
Rangwala Reshma (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2025
7:24 AM | Karyopharm Therapeutics (Filer)
| Form ARS | |
04/14/2025
7:15 AM | Karyopharm Therapeutics (Filer)
| Form DEF 14A | |
04/14/2025
7:19 AM | Karyopharm Therapeutics (Filer)
| Form DEFA14A | |
04/10/2025
4:23 PM | Affinity Asset Advisors, LLC (Filed by)
Karyopharm Therapeutics (Subject)
| Form SCHEDULE 13G | |
03/06/2025
3:13 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:48 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:49 PM | Abate Kristin (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:46 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
6:32 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
6:36 AM | Karyopharm Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2025
8:36 AM | Adage Capital Management, L.P. (Filed by)
Karyopharm Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/05/2025
3:16 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
7:34 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:03 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:07 PM | Karyopharm Therapeutics (Issuer)
Macomber Lori (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
6:08 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:35 PM | Karyopharm Therapeutics (Filer)
| Form PRE 14A | |
12/05/2024
3:15 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
6:09 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
2:50 PM | Karyopharm Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/06/2024
3:06 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
7:02 AM | Karyopharm Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/05/2024
6:47 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
6:41 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
10:49 AM | Karyopharm Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/31/2024
6:41 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
8:30 AM | HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G | |
09/05/2024
3:28 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:13 PM | Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The stealth altcoin the financial world is underestimating (Ad) The Single Most Undervalued DeFi Protocol You've Never Heard Of
If there's one cryptocurrency you should buy in this market, this token might just be it. Get the whole story on this "crypto market unicorn" right here. |
09/05/2024
3:24 PM | Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:26 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:05 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access